Patients with COVID-19: in the dark-NETs of neutrophils

M Ackermann, HJ Anders, R Bilyy, GL Bowlin… - Cell Death & …, 2021 - nature.com
SARS-CoV-2 infection poses a major threat to the lungs and multiple other organs,
occasionally causing death. Until effective vaccines are developed to curb the pandemic, it …

The transmembrane protease TMPRSS2 as a therapeutic target for COVID-19 treatment

L Wettstein, F Kirchhoff, J Münch - International Journal of Molecular …, 2022 - mdpi.com
TMPRSS2 is a type II transmembrane protease with broad expression in epithelial cells of
the respiratory and gastrointestinal tract, the prostate, and other organs. Although the …

Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection

L Wettstein, T Weil, C Conzelmann, JA Müller… - Nature …, 2021 - nature.com
SARS-CoV-2 is a respiratory pathogen and primarily infects the airway epithelium. As our
knowledge about innate immune factors of the respiratory tract against SARS-CoV-2 is …

Neutrophil extracellular traps (NETs) in severe SARS-CoV-2 lung disease

M Szturmowicz, U Demkow - International journal of molecular sciences, 2021 - mdpi.com
Neutrophil extracellular traps (NETs), built from mitochondrial or nuclear DNA, proteinases,
and histones, entrap and eliminate pathogens in the course of bacterial or viral infections …

Host serine proteases: a potential targeted therapy for COVID-19 and influenza

Y Rahbar Saadat, SM Hosseiniyan Khatibi… - Frontiers in Molecular …, 2021 - frontiersin.org
The ongoing pandemic illustrates limited therapeutic options for controlling SARS-CoV-2
infections, calling a need for additional therapeutic targets. The viral spike S glycoprotein …

Molecular mechanisms of neutrophil extracellular trap (NETs) degradation

U Demkow - International Journal of Molecular Sciences, 2023 - mdpi.com
Although many studies have been exploring the mechanisms driving NETs formation, much
less attention has been paid to the degradation and elimination of these structures. The …

[HTML][HTML] Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza

S Cambier, M Metzemaekers, AC de Carvalho… - JCI insight, 2022 - ncbi.nlm.nih.gov
Neutrophils are recognized as important circulating effector cells in the pathophysiology of
severe coronavirus disease 2019 (COVID-19). However, their role within the inflamed lungs …

Circulating calprotectin as a biomarker of COVID-19 severity

M Mahler, PL Meroni, M Infantino… - Expert review of …, 2021 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) is an infectious disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors

A Wu, K Shi, J Wang, R Zhang, Y Wang - European Journal of Medicinal …, 2024 - Elsevier
The COVID-19 pandemic, caused by SARS-CoV-2, has had a huge impact on global health.
To respond to rapidly mutating viruses and to prepare for the next pandemic, there is an …

Can fetal heart lie? Intrapartum CTG changes in COVID-19 mothers

FS Farhan, W Nori, ITA Al Kadir… - The Journal of Obstetrics …, 2022 - Springer
Background COVID-19 infection has raised multiple concerns in pregnant mothers; many
questioned the risk of vertical transmission and the implication on the feto-maternal …